BAL polyclonal, anti-human

Protein Family: Enzymes

Pathway and Disease: Lipid Metabolism

Description:
Bile salt-activated lipase (BAL) catalyzes fat and vitamin absorption. BAL acts in concert with pancreatic lipase and colipase for the complete digestion of dietary triglycerides. Defects in CEL are a cause of maturity-onset diabetes of the young type with exocrine dysfunction (MODY8), also known as diabetes and pancreatic exocrine dysfunction (DPED). MODY is a form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.

Alternate Names: Bile salt-activated lipase, BAL, Bile salt-stimulated lipase, BSSL, Caroxyl ester lipase, Sterol esterase, Pancratic lysophospholipase, Bucelipase, CEL

Application Notes: E: 1:10,000-1:50,000; WB: 1:100-1:500

Accession No.: P19835

Antigen: KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human BAL.

Format: Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4 with 0.09% sodium azide. Antibody was purified by Protein-G affinity chromatography.

Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.